EVERGREEN CAPITAL MANAGEMENT LLC
Position in PTGX — Protagonist Therapeutics, Inc
CIK 1260824
Bellevue, WA
Position in PTGX
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$346,901
+$49,673 QoQ
Shares Held
2,830
+0.4% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#240
of 341 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in PTGX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026EVERGREEN CAPITAL MANAGEMENT LLC holds $27,458,740 across 28 Biotechnology names. PTGX ranks #21 (1.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
17,761 | $11,074,693 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
4,222 | $2,097,194 | |
| 3 | ARGX |
Argenx SE
|
1,836 | $1,703,385 | |
| 4 | BMRN |
Biomarin Pharmaceutical Inc
|
22,421 | $1,282,929 | |
| 5 | 8,952 | $1,105,572 | |||
| 6 | EXEL |
Exelixis, Inc.
|
15,411 | $838,512 | |
| 7 | RPRX |
Royalty Pharma plc
|
14,344 | $804,267 | |
| 8 | CORT |
Corcept Therapeutics Inc
|
9,014 | $783,767 |
All Filings in PTGX
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $346,901 | 2,830 | Shares | Sole | 2026-07-23 | |
| 2026-03-31 | $297,228 | 2,820 | Shares | Other | 2026-05-14 | |
| 2025-12-31 | $245,600 | 2,812 | Shares | Other | 2026-01-27 | |
| No filing history on record for this holder in this stock. | ||||||